Annual ROE
0.84%
+6.78%+114.14%
30 April 2024
Summary:
PharmaCyte Biotech annual return on equity is currently 0.84%, with the most recent change of +6.78% (+114.14%) on 30 April 2024. During the last 3 years, it has risen by +54.01% (+101.58%). PMCB annual ROE is now -99.93% below its all-time high of 1284.00%, reached on 30 April 2003.PMCB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
54.01%
+53.36%+8209.23%
31 July 2024
Summary:
PharmaCyte Biotech quarterly return on equity is currently 54.01%, with the most recent change of +53.36% (+8209.23%) on 31 July 2024. Over the past year, it has increased by +55.93% (+2913.02%). PMCB quarterly ROE is now -95.25% below its all-time high of 1136.38%, reached on 31 July 2013.PMCB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMCB ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +114.1% | +2913.0% |
| 3 y3 years | +101.6% | +506.7% |
| 5 y5 years | +101.0% | +167.0% |
PMCB ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +101.6% | at high | +506.7% |
| 5 y | 5 years | at high | +101.0% | at high | +160.5% |
| alltime | all time | -99.9% | +100.0% | -95.3% | +100.0% |
PharmaCyte Biotech ROE History
| Date | Annual | Quarterly |
|---|---|---|
| July 2024 | - | 54.01%(+8209.2%) |
| Apr 2024 | 0.84%(-114.1%) | 0.65%(-134.0%) |
| Jan 2024 | - | -1.91%(-0.5%) |
| Oct 2023 | - | -1.92%(-76.6%) |
| July 2023 | - | -8.20%(+50.7%) |
| Apr 2023 | -5.94%(+26.1%) | -5.44%(-18.9%) |
| Jan 2023 | - | -6.71%(+3.4%) |
| Oct 2022 | - | -6.49%(+22.7%) |
| July 2022 | - | -5.29%(-13.0%) |
| Apr 2022 | -4.71%(-91.1%) | -6.08%(-21.1%) |
| Jan 2022 | - | -7.71%(-41.9%) |
| Oct 2021 | - | -13.28%(-74.6%) |
| July 2021 | - | -52.23%(+5.9%) |
| Apr 2021 | -53.17%(-29.3%) | -49.30%(+0.4%) |
| Jan 2021 | - | -49.10%(-15.1%) |
| Oct 2020 | - | -57.83%(-18.4%) |
| July 2020 | - | -70.87%(-12.3%) |
| Apr 2020 | -75.20%(-6.8%) | -80.81%(-9.5%) |
| Jan 2020 | - | -89.25%(+10.8%) |
| Oct 2019 | - | -80.57%(+5.2%) |
| July 2019 | - | -76.62%(+3.7%) |
| Apr 2019 | -80.71%(-31.8%) | -73.92%(-0.5%) |
| Jan 2019 | - | -74.31%(-22.7%) |
| Oct 2018 | - | -96.14%(-4.9%) |
| July 2018 | - | -101.07%(+2.2%) |
| Apr 2018 | -118.38%(+115.4%) | -98.92%(+10.7%) |
| Jan 2018 | - | -89.38%(+17.1%) |
| Oct 2017 | - | -76.32%(+12.5%) |
| July 2017 | - | -67.85%(+8.7%) |
| Apr 2017 | -54.95%(-40.9%) | -62.43%(-4.8%) |
| Jan 2017 | - | -65.57%(-10.7%) |
| Oct 2016 | - | -73.41%(-10.9%) |
| July 2016 | - | -82.41%(-8.3%) |
| Apr 2016 | -92.96%(-27.2%) | -89.91%(-18.3%) |
| Jan 2016 | - | -109.99%(+1.9%) |
| Oct 2015 | - | -107.90%(-25.1%) |
| July 2015 | - | -144.10%(+2.5%) |
| Apr 2015 | -127.65%(-58.1%) | -140.65%(-56.2%) |
| Jan 2015 | - | -320.78%(+0.6%) |
| Oct 2014 | - | -318.73%(-15.8%) |
| July 2014 | - | -378.35%(-30.1%) |
| Apr 2014 | -304.77% | -541.60%(+25.1%) |
| Jan 2014 | - | -432.96%(-64.3%) |
| Oct 2013 | - | -1214.43%(-206.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2013 | - | 1136.38%(+1109.0%) |
| Apr 2013 | 173.42%(+55.2%) | 93.99%(+0.3%) |
| Jan 2013 | - | 93.69%(+17.5%) |
| Oct 2012 | - | 79.74%(+0.6%) |
| July 2012 | - | 79.30%(-8.9%) |
| Apr 2012 | 111.73%(+118.2%) | 87.04%(-14.7%) |
| Jan 2012 | - | 102.00%(+6.0%) |
| Oct 2011 | - | 96.23%(+17.1%) |
| July 2011 | - | 82.20%(+34.8%) |
| Apr 2011 | 51.21%(-102.9%) | 61.00%(-55.2%) |
| Jan 2011 | - | 136.05%(-63.2%) |
| Oct 2010 | - | 370.18%(-143.1%) |
| July 2010 | - | -859.15%(+137.8%) |
| Apr 2010 | -1782.58%(+1236.3%) | -361.25%(+38.7%) |
| Jan 2010 | - | -260.47%(+48.3%) |
| Oct 2009 | - | -175.68%(+20.3%) |
| July 2009 | - | -146.04%(+22.4%) |
| Apr 2009 | -133.40%(+106.2%) | -119.31%(+154.8%) |
| Jan 2009 | - | -46.83%(-10.3%) |
| Oct 2008 | - | -52.23%(-21.2%) |
| July 2008 | - | -66.24%(-19.8%) |
| Apr 2008 | -64.70%(-22.2%) | -82.63%(-9.9%) |
| Jan 2008 | - | -91.72%(+1.3%) |
| Oct 2007 | - | -90.56%(+12.9%) |
| July 2007 | - | -80.19%(-14.3%) |
| Apr 2007 | -83.11%(-86.2%) | -93.54%(-68.6%) |
| Jan 2007 | - | -297.70%(-35.0%) |
| Oct 2006 | - | -457.81%(-63.1%) |
| July 2006 | - | -1241.97%(-100.0%) |
| Apr 2006 | -602.26%(-282.4%) | -11.75 M%(<-9900.0%) |
| Jan 2006 | - | 400.90%(+23.7%) |
| Oct 2005 | - | 324.18%(+15.8%) |
| July 2005 | - | 279.84%(-7.0%) |
| Apr 2005 | 330.24%(-70.8%) | 300.93%(-7.2%) |
| Jan 2005 | - | 324.36%(-56.2%) |
| Oct 2004 | - | 740.74%(-152.4%) |
| July 2004 | - | -1414.83%(+123.2%) |
| Apr 2004 | 1131.68%(-11.9%) | -633.98%(+2897.5%) |
| Jan 2004 | - | -21.15%(-21.2%) |
| Oct 2003 | - | -26.85%(-105.1%) |
| July 2003 | - | 525.48%(+105.2%) |
| Apr 2003 | 1284.00%(+240.4%) | 256.14%(+86.9%) |
| Jan 2003 | - | 137.08% |
| Apr 2002 | 377.22% | - |
FAQ
- What is PharmaCyte Biotech annual return on equity?
- What is the all time high annual ROE for PharmaCyte Biotech?
- What is PharmaCyte Biotech annual ROE year-on-year change?
- What is PharmaCyte Biotech quarterly return on equity?
- What is the all time high quarterly ROE for PharmaCyte Biotech?
- What is PharmaCyte Biotech quarterly ROE year-on-year change?
What is PharmaCyte Biotech annual return on equity?
The current annual ROE of PMCB is 0.84%
What is the all time high annual ROE for PharmaCyte Biotech?
PharmaCyte Biotech all-time high annual return on equity is 1284.00%
What is PharmaCyte Biotech annual ROE year-on-year change?
Over the past year, PMCB annual return on equity has changed by +6.78% (+114.14%)
What is PharmaCyte Biotech quarterly return on equity?
The current quarterly ROE of PMCB is 54.01%
What is the all time high quarterly ROE for PharmaCyte Biotech?
PharmaCyte Biotech all-time high quarterly return on equity is 1136.38%
What is PharmaCyte Biotech quarterly ROE year-on-year change?
Over the past year, PMCB quarterly return on equity has changed by +55.93% (+2913.02%)